IL Inhibitors Clear Path To Better Psoriasis Treatment
Executive Summary
Advances in psoriasis therapy in the last few years have revolutionized the treatment of the condition and a high percentage of patients are achieving clear or nearly clear skin, thanks to drugs targeting interleukin-17, 12 and 23. What's more, a number of payers are increasingly recognizing these new treatments as cost-effective. Scrip's infographic provides a snapshot.